Chemistry: molecular biology and microbiology – Vector – per se
Patent
1994-04-22
1997-09-23
Guzo, David
Chemistry: molecular biology and microbiology
Vector, per se
4351721, 4351723, 4352351, 536 231, 53622372, 536 241, C12N 1586, C07H 21045
Patent
active
056703678
ABSTRACT:
An improved method is described to prepare recombinant fowlpox virus for the expression of proteins or for use as a vaccine. The new method uses for the insertion of foreign DNA an intergenic region which is located between the FPV thymidine kinase (tk)gene and the 3'-open reading frame. Said intergenic region is enlarged to comprise one or more unique restriction sites, thereby allowing insertion of foreign DNA in such a way that the FPV tk-gene remains intact and codes for the entire thymidine kinase. New strong poxvirus promoters are presented and new FPV host virus strains carrying a vaccinia virus thymidine kinase gene and an E. coli lacZ gene as a novel non-essential site. The novel fowlpox virus host strains allow the use of any insertion plasmid carrying vaccinia virus tk-gene flanking regions.
REFERENCES:
patent: 5093258 (1992-03-01), Cohen et al.
patent: 5174993 (1992-12-01), Paoletti et al.
patent: 5180675 (1993-01-01), Drillien et al.
patent: 5338683 (1994-08-01), Paoletti et al.
Mackett et al. Journal of General Virology, 67:2067-2082 (1986).
Alexander et al. Journal of Virology, 66:2934-2942 (1992).
Kriajevska et al. Journal of General Virology, 74:47-53 (1993).
Jenkins et al. AIDS Research and Human Retroviruses, 7:991-998 (1991).
Piccini et al. Methods in Enzymology, 153:545-563 (1987).
De La Salle et al. Nature, 316:268-270 (1985).
Boyle et al. Gene, 35:169-177 (1985).
Wilson et al. Nucleic Acids Research, 15:4690 (1987).
Fuerst et al. Proc. Nat'l. Acad. Sci. USA, 83:8122-8126 (1986).
Fuerst et al. Molecular & Cellular Biology, 7:2538-2544 (1987).
Kumar et al., Mapping of a major early/late gene of fowlpox virus, Virus Research, 15 (1990) pp. 175-186.
Venkatesan et al., Distinctive Nucleotide Sequences Adjacent to Multiple Initiation and Termination Sites of an Early Vacinia Virus Gene, Cell, vol. 25, pp. 805-813 (Sep. 1981).
Drillien et al., "Similar Genetic Organization between a Region of Fowlpox Virus DNA and the Vaccine Virus HindIII J Fragment," Virology, 160:203-209 (1987).
Taylor et al., "Recombinant Fowlpox Virus Inducing Protective Immunity in Non-avian Species," Vaccine, 6: 497-503 (1988).
Boyle et al., "Construction of Recombinant Fowlpox Viruses As Vectors For Poultry Vaccines," Virus Research, 10: 343-356 (1988).
Davison et al., "Structure of Vaccinia Virus Early Promoters," J. Mol. Biol., 210: 749-769 (1989).
Chakrabarti et al., "Vaccinia Virus Expression Vector," Mol. and Cell. Biol., 5(12): 3403-3409 (1985).
Boyle et al., "Identification and Cloning of the Fowlpox Virus Thymidine Kinase Gene Using Vaccinia Virus," J. Gen. Virol., 67: 1591-1600 (1986).
Spehner et al., "Construction of Fowlpox Virus with Intergenic Insertions: Expression of the B-Galactosidase Gene and the Measles Virus Fusion Gene," J. Virol., 64(2): 527-533 (1990).
Kumar et al., "Activity of Fowlpox Virus Late Gene Promoter in Vaccinia and Fowlpox Virus Recombinants," Arch. Virol., 112: 139-148 (1990).
Binns et al., "Prospects for a Novel Genetically Engineered Vaccine Against Infectious Bronchitis," Isr. J. Vet. Med., 42(2): 124-127 (1986).
Dorner Friedrich
Falkner Falko Gunter
Scheiflinger Friedrich
Guzo David
Immuno Aktiengesellschaft
LandOfFree
Recombinant fowlpox virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant fowlpox virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant fowlpox virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1938352